Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ISCV | 53.45 | -2.41 | -4.31% |
| iShares Morningstar Small-Cap Value ETF | |||
| MAKX | 31.66 | -1.78 | -5.32% |
| ProShares S&P Kensho Smart Factories ETF | |||
| RPG | 33.93 | -2.42 | -6.66% |
| Invesco S&P 500® Pure Growth ETF | |||
| HAP | 44.64 | -3.64 | -7.55% |
| VanEck Natural Resources ETF | |||
| ICOP | 22.12 | -2.57 | -10.41% |
| iShares Copper and Metals Mining ETF | |||
A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with IRON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then IRON could also see price increases.
| Ticker / NAME | Correlation To ATBPF | 1D Price Change % | ||
|---|---|---|---|---|
| ATBPF | 100% | N/A | ||
| IRON - ATBPF | 53% Loosely correlated | -9.94% | ||
| KMSTF - ATBPF | 52% Loosely correlated | N/A | ||
| SRZN - ATBPF | 47% Loosely correlated | -6.39% | ||
| CDIO - ATBPF | 25% Poorly correlated | -7.31% | ||
| ZVRA - ATBPF | 22% Poorly correlated | -5.25% | ||
More | ||||